Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
40 hedge funds and large institutions have $16.6M invested in Checkpoint Therapeutics in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 6 closing their positions.
300% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 6
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
85% more capital invested
Capital invested by funds: $8.96M → $16.6M (+$7.63M)
82% more funds holding
Funds holding: 22 → 40 (+18)
0.83% more ownership
Funds ownership: 1.08% → 1.91% (+0.83%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.61M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.57M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.09M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$943K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$248K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWM
Frontier Wealth Management
Kansas City,
Missouri
|
-$603K |
| 2 |
PAS
Park Avenue Securities
New York
|
-$199K |
| 3 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$157K |
| 4 |
FAM
Fenimore Asset Management
Cobleskill,
New York
|
-$108K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$101K |
CKPT Hedge Fund Activity: Q2 2019 in Review
40 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q2 2019, worth a combined $16.6M — up 85% from $8.96M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new CKPT positions and 6 closed out — a net gain of 18 holders — while 10 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, adding an estimated $4.61M. The largest seller was Frontier Wealth Management, exiting entirely with an estimated $603K sold.
- 40 institutional investors held Checkpoint Therapeutics (CKPT) as of Q2 2019, up from 22 in Q1 2019.
- Funds reported $16.6M of Checkpoint Therapeutics stock for Q2 2019, up 85% quarter-over-quarter.
- 24 funds opened new Checkpoint Therapeutics positions in Q2 2019 and 6 closed out, a net change of +18 holders.
- The largest Checkpoint Therapeutics buyer in Q2 2019 was BlackRock, an estimated $4.61M added.
- The largest Checkpoint Therapeutics seller in Q2 2019 was Frontier Wealth Management, an estimated $603K sold.
Based on aggregated 13F filings for Q2 2019.